IQVIA™ Real-World Insights Bibliography

Assessing definitions and incentives adopted for innovation for pharmaceutical products in five high-income countries: a systematic literature review
Author(s): Naohiko Wakutsu 1, Emi Hirose 2, Naohiro Yonemoto 3, Sven Demiya 4 (rwesheorj 4)
Affiliations(s): 1) Graduate School of Economics, Nagoya City University, Nagoya, Japan 2) Health & Value, Pfizer Japan Inc., Tokyo, Japan. emi.hirose@pfizer.com 3) Health & Value, Pfizer Japan Inc., Tokyo, Japan 4) IQVIA Solutions Japan K.K., Tokyo, Japan
Publication(s):  Pharmaceutical Medicine
Document Type(s): Article,
Countries: France, Germany, Japan, UK, USA,
Click here for the abstract
C:
Y:
Miscellaneous,
2023
  L:
A:
English
Literature Review,
  Add to report
 
 
The emerging role of real-world data in advanced breast cancer therapy: Recommendations for collaborative decision-making
Author(s): Paul Cottu 1, Scott David Ramsey 2, Oriol Solà-Morales 3, Patricia A Spears 4, Lockwood Taylor 5
Affiliations(s): 1Department of Medical Oncology, Institut Curie, 26 Rue D'Ulm, 75005, Paris, France. Electronic address: paul.cottu@curie.fr. 2Hutchinson Institute for Cancer Outcomes Research, Fred Hutchinson Cancer Research Center, 1100 Fairview Avenue North, M2-B232, Seattle, WA, 98155, USA. Electronic address: sramsey@fredhutch.org. 3Health Innovation Technology Transfer Foundation, Aragó 60, E-08015, Barcelona, Spain. Electronic address: osola@fhitt.org. 48605 Carolingian Court, Raleigh, NC, 27615, USA. Electronic address: paspears88@gmail.com. 5Epidemiology, Real World Solutions at IQVIA, 4820 Emperor Boulevard, Durham, NC, 27703, USA. Electronic address: lockwood.taylor@iqvia.com.
Publication(s):  Breast. 2021 Dec 22;61:118-122. doi: 10.1016/j.breast.2021.12.015.
Document Type(s): Article,
Countries: France, Italy, USA,
Click here for the abstract
C:
Y:
Comparative Effectiveness & Health Technology Assessment, Drug safety, Oncology, Regulatory,
2022
  L:
A:
English
Review,
  Add to report
 
 
Estimating the burden of influenza-related and associated hospitalizations and deaths in France: An eight-season data study, 2010-2018
Author(s): Magali Lemaitre 1, Fayssoil Fouad 1, Fabrice Carrat 2 3, Pascal Crépey 4, Jacques Gaillat 5, Gaëtan Gavazzi 6, Odile Launay 7 8, Anne Mosnier 9, Marie-Cécile Levant 10, Mathieu Uhart 10
Affiliations(s): 1 IQVIA, Courbevoie, France. 2 Sorbonne Université, Institut National de la Santé et de la Recherche Médicale (Inserm), Institut Pierre Louis d'Epidémiologie et de Santé Publique, Paris, France. 3 Assistance Publique-Hôpitaux de Paris (AP-HP), Hôpital Saint-Antoine, Unité de Santé Publique, Paris, France. 4 Université de Rennes, EHESP, REPERES-EA 7449, Rennes, France. 5 Centre Hospitalier Annecy-Genevois, Metz-Tessy, France. 6 CHU Grenoble Alpes, Clinique Universitaire de Gériatrie, Pavillon Elisée-Chatin, and GREPI EA 7408, Université Grenoble Alpes, Grenoble, France. 7 Faculté de Médecine Paris Descartes, Université de Paris, Paris, France. 8 Inserm, CIC 1417, F-CRIN I-REIVAC, Assistance Publique-Hôpitaux de Paris, CIC Cochin-Pasteur, Paris, France. 9 Open Rome & Réseau des GROG, Paris, France. 10 Sanofi Pasteur, Lyon, France.
Publication(s):  Influenza Other Respir Viruses . 2022 Jan 10. doi: 10.1111/irv.12962.
Document Type(s): Abstract,
Countries: France,
Click here for the abstract
C:
Y:
Infectious disease, Respiratory disease,
2022
  L:
A:
English
Methodology, Population Based Study,
  Add to report
 
 
Overview of the European post-authorisation study register post-authorization studies performed in Europe from September 2010 to December 2018
Author(s): Janet Sultana 1 2, Salvatore Crisafulli 3, Mariana Almas 4, Ippazio Cosimo Antonazzo 5 6, Esme Baan 7, Claudia Bartolini 6, Maria Paola Bertuccio 3, Fedele Bonifazi 8 9, Annalisa Capuano 10 11, Antonella Didio 8 9, Vera Ehrenstein 12, Mariagrazia Felisi 8 13, Carmen Ferrajolo 10 11, Andrea Fontana 14, Remy Francisca 7, Annie Fourrier-Reglat 15, Joan Fortuny 16, Rosa Gini 6, Giulia Hyeraci 6, Christel Hoeve 7, Christos Kontogiorgis 17, Valentina Isgrò 18, Panagiotis-Nikolaos Lalagkas 17, Luca L'Abbate 18, Deborah Layton 19, Annalisa Landi 8 9, Silvia Narduzzi 19, Leonardo Roque Pereira 20, Georgios Poulentzas 17, Concetta Rafaniello 10 11, Giuseppe Roberto 6, Giulia Scondotto 3, Liberata Sportiello 10 11, Maddalena Toma 8 9, Massoud Toussi 19, Katia Verhamme 7, Elisabetta Volpe 8 9, Gianluca Trifirò 18,
Affiliations(s): Pharmacy Department, Mater Dei Hospital, Msida, Malta. 2Exeter College of Medicine and Health, Exeter, UK. 3Department of Medicine, University of Verona, Verona, Italy. 4Real World Solutions Department, IQVIA, Lisbon, Portugal. 5Research Centre on Public Health (CESP), University of Milan-Bicocca, Milan, Italy. 6Agenzia Regionale di Sanità della Toscana, Florence, Italy. 7Department of Medical Informatics, Erasmus Medical Centre, Rotterdam, The Netherlands. 8TEDDY European Network of Excellence for Paediatric Clinical Research, Pavia, Italy. 9Fondazione per la Ricerca Farmacologica Gianni Benzi Onlus, Bari, Italy. 10Department of Experimental Medicine, University of Campania "Vanvitelli", Naples, Italy. 11Campania Regional Center of Pharmacovigilance and Pharmacoepidemiology, Naples, Italy. 12Department of Clinical Epidemiology, Aarhus University Hospital, Aarhus, Denmark. 13CVBF Consorzio per Valutazioni Biologiche e Farmacologiche, Pavia, Italy. 14Unit of Biostatistics, Fondazione IRCCS Casa Sollievo della Sofferenza, San Giovanni Rotondo, Italy. 15Univ. Bordeaux, INSERM, Bordeaux Population Health Research Center, Team of Pharmacoepidemiology, UMR 1219, Bordeaux, France. 16RTI Health Solutions, Barcelona, Spain. 17Democritus University of Thrace, Alexandroupolis, Greece. 18Department of Diagnostics and Public Health, University of Verona, Verona, Italy. 19Data Science Hub, Real World Solutions, IQVIA, London, UK. 20Department of Datascience & Biostatistics, University Medical Center Utrecht, Utrecht, The Netherlands.
Publication(s):  Pharmacoepidemiol Drug Saf . 2022 Jun;31(6):689-705. doi: 10.1002/pds.5413. Epub 2022 Feb 11.
Document Type(s): Article,
Countries: Denmark, France, Italy, Netherlands, Portugal, Spain, UK,
Click here for the abstract
C:
Y:
Drug safety, Drug Utlization Study,
2022
  L:
A:
English
Database Study, Review,
  Add to report
 
 
Risk Factors and Medical Resource Utilization of Respiratory Syncytial Virus, Human Metapneumovirus and Influenza Related Hospitalizations in Adults ? A Global Study During the 2017-2019 Epidemic Seasons (Hospitalized Acute Respiratory Tract Infection [HARTI] Study)
Author(s): Ann R Falsey, Edward E Walsh, Stacey House, Yannick Vandenijck, Xiaohui Ren, Sofia Keim, Diye Kang, Pascale Peeters, James Witek, Gabriela Ispas
Affiliations(s): University Of Rochester School Of Medicine and Rochester Regional Health, Rochester, NY, United States; Washington University School of Medicine, St Louis, MO, United States; Janssen Infectious Diseases, Beerse, Belgium; IQVIA Real-World Solutions, Courbevoie, France; Janssen Research & Development, LLC, Titusville, NJ, United States
Publication(s): 
Document Type(s): Article,
Countries: Argentina, Australia, Brazil, Canada, France, Germany, Japan, Korea, Malaysia, Mexico, South Africa, USA,
Click here for the abstract
C:
Y:
Infectious disease,
2021
  L:
A:
English
Burden of illness, Clinical setting: hospital, Epidemiological study, Observational study, Patient questionnaire, Prospective study,
  Add to report
 
 
Impact of extending direct antiviral agents (DAA) availability in France: an observational cohort study (2015-2019) of data from French administrative healthcare databases (SNDS)
Author(s): Stanislas Pol 1, Fayssoil Fouad 2, Magali Lemaitre 2, Ingrid Rodriguez 3, Olivier Lada 3, Pascaline Rabiega 2, Elias Benabadji 3, Françoise Roudot-Thoraval 4
Affiliations(s): 1Université de Paris, département d'hépatologie et d'addictologie, 75014 Cochin (AP-HP), Paris, France. 2IQVIA, 92400 Courbevoie, France. 3Gilead Sciences, 92100 Boulogne Billancourt, France. 4Service d'hépatologie, Henri-Mondor (AP-HP), 94010, Créteil, France.
Publication(s):  Lancet Reg Health Eur . 2021 Dec 11;13:100281. doi: 10.1016/j.lanepe.2021.100281. eCollection 2022 Feb.
Document Type(s): Abstract,
Countries: France,
Click here for the abstract
C:
Y:
Immunology and Vaccination, Infectious disease,
2021
  L:
A:
English
Observational study, Population Based Study, Predictive analytics,
  Add to report
 
 
Economic and disease burden of RSV-associated hospitalizations in young children in France, from 2010 through 2018
Author(s): C Demont 1, N Petrica 2, I Bardoulat 2, S Duret 2, L Watier 3, A Chosidow 4, M Lorrot 4, A Kieffer 5, M Lemaitre 2
Affiliations(s): 1Sanofi Pasteur, 14 Espace Henry Vallée, 69007, Lyon, France. Clarisse.Demont@sanofi.com. 2IQVIA, 92400, Courbevoie, France. 3Université Paris-Saclay, UVSQ, Inserm, CESP, 94807, Villejuif, France. 4Department of Pediatrics, Armand Trousseau Hospital (AP-HP), 75012, Paris, France. 5Sanofi Pasteur, 14 Espace Henry Vallée, 69007, Lyon, France.
Publication(s):  BMC Infect Dis . 2021 Aug 2;21(1):730. doi: 10.1186/s12879-021-06399-8.
Document Type(s): Abstract,
Countries: France,
Click here for the abstract
C:
Y:
Infectious disease, Respiratory disease,
2021
  L:
A:
English
Observational study, Population Based Study,
  Add to report
 
 
Monitoring outpatient antibiotic utilization using reimbursement and retail sales data: a population-based comparison in France, 2012-17
Author(s): Nhung T H Trinh 1 2, Martin Chalumeau 1 3, Tim A Bruckner 4, Corinne Levy 5 6, Antoine Bessou 2, Dejan Milic 2, Robert Cohen 5 7, Magali Lemaitre 2, Jérémie F Cohen 1 3
Affiliations(s): 1Université de Paris, Epidemiology and Statistics Research Center-CRESS, INSERM, Obstetrical, Perinatal and Pediatric Epidemiology research team, F-75004, Paris, France. 2IQVIA, La Défense, France. 3Department of General Pediatrics and Pediatric Infectious Diseases, AP-HP, Hôpital Necker-Enfants malades, Université de Paris, Paris, France. 4Program in Public Health, University of California, Irvine, CA, USA. 5Association Clinique et Thérapeutique Infantile du Val-de-Marne (ACTIV), Saint-Maur-des-Fossés, France. 6Clinical Research Centre, Centre Hospitalier Intercommunal de Créteil, Créteil, France. 7Université Paris Est, IMRB-GRC GEMINI, Créteil, France.
Publication(s):  J Antimicrob Chemother . 2021 Aug 12;76(9):2446-2452. doi: 10.1093/jac/dkab185.
Document Type(s): Article,
Countries: France,
Click here for the abstract
C:
Y:
Drug Utlization Study,
2021
  L:
A:
English
Population Based Study,
  Add to report
 
 
Étude EPILYMIA – Étude rétrospective combinant trois sources de données pour l’estimation de l’incidence de la borréliose de Lyme en France entre 2015 et 2019
Author(s): AntoineBessou1 StéphanieDuret1 MagaliLemaître1 CharlesNuttens2
Affiliations(s): 1 IQVIA France, Courbevoie, France 2 Pfizer SAS France, Paris, France
Publication(s):  https://doi.org/10.1016/j.respe.2021.05.024
Document Type(s): Article,
Countries: France,
Click here for the abstract
C:
Y:
Infectious disease,
2021
  L:
A:
French
Population Based Study,
  Add to report
 
 
Refracture and mortality following hospitalization for severe osteoporotic fractures: The Fractos Study
Author(s): Christian Roux 1, Thierry Thomas 2, Julien Paccou 3, Geoffray Bizouard 4, Anne Crochard 5, Emese Toth 5, Magali Lemaitre 4, Frédérique Maurel 4, Laure Perrin 5, Florence Tubach 6
Affiliations(s): 1 Department of Rheumatology Cochin Hospital, Assistance Publique - Hôpitaux de Paris Centre, Institut National de la Santé et de la Recherche Médicale (INSERM) Unités Mixtes de Recherche (UMR) 1153, Université de Paris Paris France. 2 Department of Rheumatology Hôpital Nord, Centre Hospitalier Universitaire (CHU) Saint-Etienne, INSERM U1059, Lyon University Saint-Etienne France. 3 Department of Rheumatology Lille University, CHU Lille, Marrow Adiposity and Bone Laboratory (MABlab) ULR 4490 Lille France. 4 IQVIA Courbevoie France. 5 UCB Pharma Colombes France. 6 Department of Public Health, Pharmacoepidemiology Center (Cephepi) Sorbonne University, INSERM, Institut Pierre Louis d'Epidémiologie et de Santé Publique, AP-HP Sorbonne University, Pitié-Salpêtrière Hospital, CIC-1422 Paris France.
Publication(s):  JBMR Plus . 2021 May 14;5(7):e10507. doi: 10.1002/jbm4.10507. eCollection 2021 Jul.
Document Type(s): Abstract,
Countries: France,
C:
Y:
Orthopedics,
2021
  L:
A:
English
Population Based Study,
  Add to report
 
 
 1 of 36 Next Page Last Page